title: Influence of intestinal efflux pumps on the absorption and transport of furosemide.
abstract: OBJECTIVE
  Furosemide is a commonly used diuretic which is used in the treatment of edema, congestive heart failure, hypertension and renal failure. Its absorption exhibits inter- and intra-subject variability that can be attributed to many factors including the intestinal efflux pumps such as the P-glycoprotein (P-gp). This study was done due to the great disagreement between what is published in the literature regarding the influence of P-gp on furosemide and at the same time due to the importance of this drug in the treatment of different conditions as described above. In addition, an investigation of the effect of two of the commonly used pharmaceutical excipients (hydroxypropyl β-cyclodextrin [HPβCD] and Tween 80) and also a P-gp inhibitor (verapamil hydrochloride) on the intestinal absorption of this drug were also done.
  
  
  METHODS
  The study utilized the everted intestinal sacs technique to investigate both the effect of the efflux transporter (P-gp) on furosemide absorption and also the effect of the chosen excipients.
  
  
  RESULTS
  The absorption of furosemide was significantly influenced by the P-gp as confirmed by the everted vis the non-everted sacs together with the verapamil study in which the transport of furosemide was inhibited by verapamil. In addition, Tween 80 was also shown to inhibit the P-gp pump whereas the HPβCD did not significantly influence the efflux of furosemide in this study.
  
  
  CONCLUSIONS
  P-glycoprotein and some of the used excipients in the formulation play a very important role in the transport of furosemide and other drugs. Thus excipients that affect the activity of P-gp should be avoided when formulating drugs that are substrate for the P-gp or other efflux pumps.
authors: Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
authors: Abdullah M
authors: AM
authors: Al-Mohizea
keywords: Furosemide efflux; Furosemide intestinal absorption; Intestinal efflux
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):347-52
references: 15556552
references: J Pharm Sci. 1998 Dec;87(12):1604-7
references: 10189274
references: J Pharmacol Exp Ther. 2001 Nov;299(2):620-8
references: 11602674
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 15;859(2):261-6
references: 17936093
references: J Pharm Sci. 2005 Aug;94(8):1694-704
references: 15986467
references: J Pharm Sci. 2005 Dec;94(12):2632-43
references: 16258992
references: J Pharm Sci. 2001 Nov;90(11):1776-86
references: 11745735
references: Arch Pharm Res. 2003 Sep;26(9):768-72
references: 14560928
references: J Pharm Sci. 2008 Mar;97(3):1071-88
references: 17694541
references: Eur J Pharm Biopharm. 2002 May;53(3):311-5
references: 11976019
references: Eur J Clin Pharmacol. 1984;26(2):197-207
references: 6723758
references: Adv Drug Deliv Rev. 2001 Oct 1;50 Suppl 1:S13-31
references: 11576693
references: J Control Release. 2003 Jun 5;90(1):37-48
references: 12767705